Chinese Biotech Firm Realbio Raises Nearly $15M Series A+ Round

For Digital Subscribers Only

Chinese biotechnology firm Realbio Technology has raised nearly RMB100 million (US$14.93 million) in a series A round of financing led by Chinese venture capital firm Shandong Luxin High-Tech Industry, according to a statement released on Wednesday.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

China Expert network

RELATED NEWS



LEAVE A REPLY